BALYASNY ASSET MANAGEMENT L.P. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,890,743
-81.3%
408,297
-66.6%
0.01%
-87.2%
Q3 2022$15,419,000
+22.0%
1,223,721
+2.4%
0.05%
+14.6%
Q2 2022$12,638,000
+61.8%
1,194,511
-69.4%
0.04%
-55.4%
Q1 2020$7,811,000
+14364.8%
3,905,676
+35114.8%
0.09%
Q4 2017$54,000
-80.9%
11,091
-79.4%
0.00%
-100.0%
Q3 2017$282,000
-78.3%
53,796
-38.2%
0.00%
-87.5%
Q2 2015$1,301,00087,1110.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
VHCP Management II, LLC 6,071,142$38,430,00018.43%
RTW INVESTMENTS, LP 4,078,895$25,819,0009.72%
VHCP Management, LLC 1,155,104$7,312,0007.86%
RA Capital Management 2,989,795$18,925,0002.68%
DLD Asset Management, LP 1,258,700$7,967,0002.61%
Avoro Capital Advisors LLC 1,631,502$10,327,0002.09%
Ghost Tree Capital, LLC 1,150,000$7,280,0001.75%
GREAT POINT PARTNERS LLC 725,000$4,589,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,237,734$20,495,0000.84%
Baker Brothers Advisors 10,963,944$69,402,0000.68%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders